Qiming Kan
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 25
- Biomaterials 20
- Nanoparticle-Based Drug Delivery 19
- Co-authors
- Zhonggui He (28 shared papers)Jin Sun (25 shared papers)Cong Luo (15 shared papers)Haotian Zhang (13 shared papers)Xuanbo Zhang (12 shared papers)Bingjun Sun (11 shared papers)Yongjun Wang (11 shared papers)Menglin Wang (7 shared papers)
- Journals
- Asian Journal of Pharmaceutical Sciences (5 papers)Biomaterials (3 papers)Journal of Controlled Release (3 papers)Biomaterials Science (3 papers)Drug Delivery (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Qiming Kan
40 papers receiving 2.4k citations
Qiming Kan's Hit Papers
Peers
Comparison fields: 5 of 101
- Biomaterials 1.1k
- Biomedical Engineering 1.4k
- Pharmaceutical Science 131
- Molecular Biology 908
- Biochemistry 94
Countries citing papers authored by Qiming Kan
This map shows the geographic impact of Qiming Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiming Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiming Kan more than expected).
Fields of papers citing papers by Qiming Kan
This network shows the impact of papers produced by Qiming Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiming Kan. The network helps show where Qiming Kan may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiming Kan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy Hit paper breakdown → | 2018 | 378 |
| 2 | 2019 | 272 | |
| 3 | 2019 | 150 | |
| 4 | 2019 | 143 | |
| 5 | 2020 | 115 | |
| 6 | 2020 | 109 | |
| 7 | 2016 | 91 | |
| 8 | 2018 | 89 | |
| 9 | 2021 | 80 | |
| 10 | 2018 | 74 | |
| 11 | 2016 | 67 | |
| 12 | 2021 | 64 | |
| 13 | 2018 | 59 | |
| 14 | 2018 | 48 | |
| 15 | 2021 | 46 | |
| 16 | 2019 | 43 | |
| 17 | 2018 | 41 | |
| 18 | 2018 | 41 | |
| 19 | 2018 | 40 | |
| 20 | 2016 | 40 |
About Qiming Kan
Qiming Kan is a scholar working on Biomedical Engineering, Biomaterials, Molecular Biology, Pulmonary and Respiratory Medicine and Materials Chemistry, having authored 41 papers that have together received 2.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (19 papers), Photodynamic Therapy Research Studies (6 papers), RNA Interference and Gene Delivery (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Extracellular vesicles in disease (3 papers), Advanced Nanomaterials in Catalysis (3 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Biomaterials (1.1k citations), Biomedical Engineering (1.4k citations), Pharmaceutical Science (131 citations), Molecular Biology (908 citations) and Biochemistry (94 citations). Qiming Kan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zhonggui He, Jin Sun, Cong Luo, Haotian Zhang, Xuanbo Zhang, Bingjun Sun, Yongjun Wang, Menglin Wang, Yu Han and Qin Chen. Their work appears in journals such as Asian Journal of Pharmaceutical Sciences, Biomaterials, Journal of Controlled Release, Biomaterials Science and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.